GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (FRA:VTFN) » Definitions » Price-to-Free-Cash-Flow

Vitrolife AB (FRA:VTFN) Price-to-Free-Cash-Flow : 32.89 (As of May. 27, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB Price-to-Free-Cash-Flow?

As of today (2024-05-27), Vitrolife AB's share price is €15.95. Vitrolife AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.49. Hence, Vitrolife AB's Price-to-Free-Cash-Flow Ratio for today is 32.89.

The historical rank and industry rank for Vitrolife AB's Price-to-Free-Cash-Flow or its related term are showing as below:

FRA:VTFN' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 16.14   Med: 47.22   Max: 162.13
Current: 33.58

During the past 13 years, Vitrolife AB's highest Price-to-Free-Cash-Flow Ratio was 162.13. The lowest was 16.14. And the median was 47.22.

FRA:VTFN's Price-to-Free-Cash-Flow is ranked better than
50.15% of 331 companies
in the Medical Devices & Instruments industry
Industry Median: 33.58 vs FRA:VTFN: 33.58

Vitrolife AB's Free Cash Flow per Share for the three months ended in Mar. 2024 was €0.10. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €0.49.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Vitrolife AB was 9.70% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 15.00% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 19.80% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 15.00% per year.

During the past 13 years, Vitrolife AB's highest 3-Year average Free Cash Flow per Share Growth Rate was 138.10% per year. The lowest was -31.30% per year. And the median was 16.10% per year.


Vitrolife AB Price-to-Free-Cash-Flow Historical Data

The historical data trend for Vitrolife AB's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Price-to-Free-Cash-Flow Chart

Vitrolife AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.72 69.64 200.00 45.92 41.32

Vitrolife AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.30 39.38 27.12 41.32 36.00

Competitive Comparison of Vitrolife AB's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Vitrolife AB's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Price-to-Free-Cash-Flow falls into.



Vitrolife AB Price-to-Free-Cash-Flow Calculation

Vitrolife AB's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=15.95/0.485
=32.89

Vitrolife AB's Share Price of today is €15.95.
Vitrolife AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.49.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Vitrolife AB  (FRA:VTFN) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Vitrolife AB Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Vitrolife AB (FRA:VTFN) Business Description

Traded in Other Exchanges
Address
Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (FRA:VTFN) Headlines

No Headlines